UTSW researchers discover how food-poisoning bacteria infect the intestines
Researchers at the University of Texas Southwestern Medical Center have discovered how a bacterium that infects people after they eat raw or undercooked shellfish creates syringe-like structures to inject its toxins into intestinal cells. The findings, published in , could lead to new ways to treat food poisoning caused by Vibrio parahaemolyticus.

“We have provided the first visual evidence of how a gut bacterial pathogen uses this assembly method to build a syringe to deliver a lethal injection to intestinal cells,” said a professor of molecular biology and biochemistry and a Howard Hughes Medical Institute investigator at UTSW. “This work provides a new view of how enteric bacteria when exposed to bile acids efficiently respond and build a virulence system.”

V. parahaemolyticus, commonly found in warm coastal waters, is a leading cause of seafood-related food poisoning. People infected often have diarrhea, cramping, vomiting, fever and chills.
Researchers knew that V. parahaemolyticus injects molecules into human cells using a structure called the type III secretion system 2 (T3SS2). However, these syringes, composed of 19 different proteins, are not produced or assembled until the bacteria are inside the intestines. Scientists were not sure exactly how this occurs.
The latest findings build on the work of a by the . Orth and her colleagues tagged components of the V. parahaemolyticus T3SS2 with fluorescent markers and used super-resolution microscopy to track their locations as the bacteria were grown in different conditions. The researchers discovered that when V. parahaemolyticus is exposed to bile acids — digestive molecules in the intestines — the bacteria move DNA containing the T3SS2 genes close to their membrane.
Then, at the exact site where the T3SS2 is needed, V. parahaemolyticus transcribes that DNA into RNA, translates the RNA into protein, and assembles the components of the T3SS2 through the membrane in a process known as transertion. “It is like watching the assembly of a factory that produces a large molecular machine within an hour,” Orth said.

These steps were previously thought to occur in more disparate locations around a cell, but pulling the machinery together into one place on the bacterium’s membrane likely helps V. parahaemolyticus more quickly and efficiently build the T3SS2 and infect cells. Since other disease-causing gut bacteria contain molecular components similar to V. parahaemolyticus, the phenomenon of transertion may be widely used, the researchers hypothesize.
“Our findings imply that other gastrointestinal pathogens may also use this mechanism to mediate efficient assembly of complex molecular machines in response to environmental cues,” said UTSW research specialist , first author of the paper.
More work is needed to know which bacteria use transertion to build their T3SS structures and whether drugs could be developed that block transertion to treat V. parahaemolyticus infections.
UTSW researcher also contributed to this study.
This article was first published by the University of Texas Southwestern Medical Center.
Enjoy reading 91影库Today?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreGet the latest from 91影库Today
Enter your email address, and we鈥檒l send you a weekly email with recent articles, interviews and more.
Latest in Science
Science highlights or most popular articles

Hope for a cure hangs on research
Amid drastic proposed cuts to biomedical research, rare disease families like Hailey Adkisson鈥檚 fight for survival and hope. Without funding, science can鈥檛 鈥渃atch up鈥 to help the patients who need it most.

Before we鈥檝e lost what we can鈥檛 rebuild: Hope for prion disease
Sonia Vallabh and Eric Minikel, a husband-and-wife team racing to cure prion disease, helped develop ION717, an antisense oligonucleotide treatment now in clinical trials. Their mission is personal 鈥 and just getting started.

Defeating deletions and duplications
Promising therapeutics for chromosome 15 rare neurodevelopmental disorders, including Angelman syndrome, Dup15q syndrome and Prader鈥揥illi syndrome.

Using 'nature鈥檚 mistakes' as a window into Lafora disease
After years of heartbreak, Lafora disease families are fueling glycogen storage research breakthroughs, helping develop therapies that may treat not only Lafora but other related neurological disorders.

Cracking cancer鈥檚 code through functional connections
A machine learning鈥揹erived protein cofunction network is transforming how scientists understand and uncover relationships between proteins in cancer.

Gaze into the proteomics crystal ball
The 15th International Symposium on Proteomics in the Life Sciences symposium will be held August 17鈥21 in Cambridge, Massachusetts.